EHDS stakeholder meeting with EU officials
Read more6 September 2023, Brussels – PIONEER as part of a multi-stakeholder group consisting of 32 European patient organisations, medical associations, research organisations, data collaborations and industry associations met EU officials, including MEP Tomislav Sokol, Co-Rapporteur, as well as several...
PIONEER and the Chinese University of Hong Kong Started a Big Data Collaboration to Fight Prostate Cancer Worldwide
Read moreThe European funded prostate cancer project PIONEER – Big Data in Prostate Cancer and the Faculty of Medicine of The Chinese University of Hong Kong have signed a data sharing agreement to ensure more data diversity and a better...
Joint Statement: health organisations define EHDS’ opt out required for life saving research
Read moreOn 6 June, PIONEER joined together with 31 other health stakeholders to share views on specific recommendations for a potential opt-out mechanism in the future EHDS. These organisations and initiatives have joined forces because they all share the view...
Stakeholders’ consensus response to the proposed European Health Data Space
Read moreOn 20 October, PIONEER joined a group of 29 stakeholders in welcoming the European Commission’s proposal on the European Health Data Space. The stakeholders, which include medical professional and research organisations, patient representatives, industry associations and data collaborations strongly...
Latest Interviews with the Patient-reported Outcome Measures & Core Outcome Set Working Groups
Read moreCatch up on all the developments related to the PIONEER patient-related outcome measures and core outcome set working groups. Find the latest publications as well as two in-depht interviews with the PIONEER members tackling these important research areas here!
Press release: SAS deploys SAS Viya in the central PIONEER Big Data Platform for Prostate Cancer
Read morePIONEER: The International Network of Excellence for Big Data in Prostate Cancer announces that consortium partner SAS has deployed their latest advanced analytics capabilities in the central PIONEER Big Data Platform for Prostate Cancer. In partnership with the Center...
Contact us here
PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. IMI2 receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
